Congratulations to Clarity Medical Group Holding Ltd. (1406.HK) on its Successful Listing

Clarity Medical Group Holding Ltd. has been successfully listed on the Mainboard of HKSE on 18 February 2022. AVISTA Group is honored to be engaged in providing valuation services with regards to this listing application.

Clarity Medical Group Holding Ltd. is a private healthcare institution specialising in ophthalmology. It provides comprehensive ophthalmic services to patients with a focus on offering various refractive treatment services including SMILE surgeries, multifocal IOL replacements and ICL implantations. Different treatments for other eye problems, such as standard cataract surgeries, laser procedures, PPV surgeries, other treatments and surgeries, medical consultation and examination services and sales of prescriptions and others are also available.

According to Frost & Sullivan, Clarity Medical ranked fourth in ophthalmic healthcare services, in terms of revenue, among all private healthcare institutions in Hong Kong in 2020, with a market share of 5.0%. Clarity Medical also ranked first in SMILE surgery; the second in multifocal IOL replacement; and the first in ICL implantation, in terms of revenue generated from respective treatments in 2020. During 2020, Clarity Medical accounted for approximately 38.0% of Hong Kong’s SMILE surgery market by revenue; approximately 6.0% of Hong Kong’s multifocal IOL replacement market by revenue; and approximately 46.4% of Hong Kong’s ICL implantation market by revenue.

Meet Our People

IVAN LUI

IVAN LUI

Director

VALUATION ADVISORY

ivan.lui@avaval.com

Date: 18 Feb 2022 | Tags: Business Valuation, Initial Public Offering (IPO)

Privacy & Disclaimer

© COPYRIGHT 2020 AVISTA GROUP, ALL RIGHTS RESERVED

沪ICP备17054339号